Trackpad

Medicamen Biotech forays into domestic markets via subsidiary 

The pharmaceuticals major Medicamen Biotech has announced that it is foraying into the domestic business with its subsidiary - Medicamen Life Sciences Private Limited. In a press release, Medicamen Group Chairman Rahul Bishnoi stated, “The vision of the company is to become the most-admired pharmaceutical organisation by offering research & data backed, affordable & quality medicines for Indian population and to start with, the company has entered cardiovascular & diabetes (CVD) business, which contributes annual revenue of more than Rs 50,000 crore to IPM with a CAGR of 11 per cent.”

Kamal Pahwa, a pharma veteran with 32 years of experience in the CVD business, and Pramod Sharma of Neelkanth Drugs Pvt Ltd, a leading distribution network in India have joined hands with Medicamen to launch this venture. Medicamen Biotech Limited develops & markets a wide range of branded and generic formulations in the pharmaceutical industry. The company is engaged in the manufacturing & marketing of branded and generic pharmaceutical formulations in the overseas as well as domestic markets. It is a manufacturer & supplier of a range of products such as tablets, capsules, ointment, liquid syrup, and dry syrup. It has recently commenced its state-of-the-art oncology plant at Haridwar, which is meant for regulated markets like US and Europe. Earlier this year, the company launched its high-quality oncology products in the domestic market.

Sterlite Tech unveils 5G cosmos to help Indian telcos fiberise their networks for 5G!

Sterlite Technologies Limited, one of the industry’s leading integrators of digital networks, on Sunday it unveiled 5G Cosmos - an optical solution for towers and small cells - to lend speed to the 5G rollout. As India approaches the much-awaited 5G buildouts, telecom operators need to look at fiberisation with a futuristic lens. India’s fiberisation will increase 3X to 60 Mn fkm annually. Tower and small cell fiberisation will be big drivers. Tower fiberisation must increase from 35 per cent to 80 per cent to provide high quality 5G services. Additionally, 5G will require upto 4times small cells, backhauled with fibre.

Despite the intent and capital availability, India’s fibre space is constrained by deployment speed and scale. 5G Cosmos is an Atmanirbhar, patented solution that can solve these challenges and connect every tower, small cell and node. It comprises of:

1. 5G optical network topology design- The design will deliver a highly competent network with enhanced scalability, bandwidth, and reduced latency

2. Stellar Fibre- This bend insensitive fibre, apt for congested 5G topology, minimises data loss and ensures speed through seamless splicing

3. Celesta intelligently bonded ribbon cables- These high-density cables will reduce installation time and optimise project costs

4. Plug-and-Play optical devices- STL’s Opto-Bolt and Opto-Blaze offer a pre-connectorised, ruggedised Plug-and-play solution, resulting in faster execution and deskilling of field installations

5. Automation-led fibre deployment- This technology-led approach offers backhaul fiberisation using robotics and AIdriven field management systems.

Launching 5G Cosmos at IMC 2022, Pankaj Miglani, Director Supply Chain Management, Bharti Airtel, said: “We are readying our infrastructure for 5G and fiberisation is a core need. We are happy to see the use cases that 5G Cosmos can solve for telcos and enable us to deliver a great 5G experience to our customers.

EKI Energy subsidiary completes capacity expansion to achieve one of world’s highest production capacities

EKI Energy Services Limited is a leading carbon credit developer & supplier across the globe. The company has been passionately working towards rehabilitating the planet to a future of net-zero carbon emissions. With an aim to contribute to the development of a climate-resilient global economy, the company offers strategic solutions to businesses & organisations globally to achieve their climate ambition. As of today, the company is present in over 16 countries and has more than 3,000 clients across around 40 countries worldwide. As of date, EKI has supplied over 180 million offsets. 

In a recent development, the company announced that its subsidiary - GHG Reduction Technologies Pvt Ltd - has completed the capacity expansion to achieve one of the highest production capacities in the world. The company’s manufacturing plant, located in Nashik, now has a capacity to manufacture five million improved cookstoves per year, the highest ever in the biomass category. These improved cookstoves are being supplied for the clean cooking projects of major oil & gas players across the globe.

Fineotex Chemical JV partner HealthGuard AMIC gets approved by United States (US) Environmental Protection Agency (EPA)

Fineotex Chemical Limited has announced that HealthGuard's market-leading, non-heavy metal base anti-microbial treatment, HealthGuard AMIC, has been approved by the US Environmental Protection Agency (EPA). In order to become the sole global marketing & sales channel partner with joint operations out of Malaysia, Fineotex Chemical Limited and HealthGuard® Australia formed a joint venture last year.

HG AMIC is a substance that can be used in manufacturing operations to combat germs that cause odours and stains. In the course of production, it is absorbed into raw materials to create finished goods. It prevents the formation of bacteria, fungi, mould, algae, and mildew that result in offensive odours, colour changes, stains, degradation, as well as corrosion. With this EPA approval, the timing is right to react to innumerable market requests by opening doors to the US market for premium HG AMIC, which possesses a sterling safety record and has been successfully commercialised throughout the world for more than 25 years. HealthGuard AMIC EPA licence, which boasts of over 70 approved site applications, permits the export of treated goods to the US.

BSE receives final SEBI approval to launch EGR as a new segment

Bombay Stock Exchange (BSE), India's leading and most diverse exchange has received final approval from the capital markets regulator Securities and Exchange Board of India (SEBI) for introducing the Electronic Gold Receipt (EGR) segment on its platform. BSE received in-principle approval from SEBI in February 2022, after which the exchange conducted several mock trading in the test environment for exchange members to facilitate trading in EGRs. EGRs will cater to all market participants, which means that buyers and sellers on the exchange shall include individual investors, as well as commercial participants along the value chain like importers, banks, refiners, bullion traders, jewellery manufacturers, and retailers.

Shri. Sameer Patil, CBO - BSE said, "We are extremely thankful to SEBI for giving us the final approval and confidence that we will be able to launch the trading in EGR soon, as gold holds special significance for Indian households. BSE is confident, that the EGR platform will lead to greater assurance in the quality of gold supplied, efficient price discovery, and transparency in transacting. This can create a vibrant gold ecosystem in India by enabling actual fungibility of gold, which is the need of the hour.”

BSE is working with all depositaries and vaults to ensure the development of the entire ecosystem around EGR trade including depositaries, vault managers, traders, bullion dealers, and jewellers so that EGRs will go a long way in building a transparent channel for gold trade on a national institutionalized platform. India is the second largest consumer of gold globally with annual gold demand of approximately 800-900 tonnes and holds an important position in the global markets. India has remained a price-taker in the global markets, and at present, does not play any significant role in influencing the price-setting for the commodity. A platform for EGR infuses transparency in gold spot transactions, enables India to emerge as the price setter, and would eliminate existing market inefficiencies.